Beximco Pharma formally acquires majority stake of Sanofi Bangladesh

Beximco Pharmaceuticals Limited has completed its acquisition process of the majority stake - 54.6 per cent - in Sanofi Bangladesh Limited.

The homegrown drug-making giant held a brief ceremony to mark the landmark acquisition at a hotel in the capital on Thursday, said a press release.

Beximco Pharma’s Managing Director Nazmul Hassan MP, Bangladesh Chemical Industries Corporation (BCIC) Chairman Shah Md Imdadul Haque, and senior officials from both the companies attended the meeting.

A five-member new board of directors has been formed with Nazmul Hassan MP, Rabbur Reza, Ali Nawaz joining from Beximco Pharma and the BCIC chairman and an official from the Ministry of Industries representing the government.